Advanced search

SINGLE-DOSE PHARMACOKINETICS OF CEFPIROME IN PATIENTS WITH RENAL IMPAIRMENT.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Lameire, Norbert, V MALERCZYK, B DREES, K LEHR, and B ROSENKRANZ. 1992. “Single-dose Pharmacokinetics of Cefpirome in Patients with Renal Impairment.” Clinical Pharmacology & Therapeutics 52 (1): 24–30.
APA
Lameire, N., MALERCZYK, V., DREES, B., LEHR, K., & ROSENKRANZ, B. (1992). SINGLE-DOSE PHARMACOKINETICS OF CEFPIROME IN PATIENTS WITH RENAL IMPAIRMENT. CLINICAL PHARMACOLOGY & THERAPEUTICS, 52(1), 24–30.
Vancouver
1.
Lameire N, MALERCZYK V, DREES B, LEHR K, ROSENKRANZ B. SINGLE-DOSE PHARMACOKINETICS OF CEFPIROME IN PATIENTS WITH RENAL IMPAIRMENT. CLINICAL PHARMACOLOGY & THERAPEUTICS. 1992;52(1):24–30.
MLA
Lameire, Norbert, V MALERCZYK, B DREES, et al. “Single-dose Pharmacokinetics of Cefpirome in Patients with Renal Impairment.” CLINICAL PHARMACOLOGY & THERAPEUTICS 52.1 (1992): 24–30. Print.
@article{206292,
  author       = {Lameire, Norbert and MALERCZYK, V and DREES, B and LEHR, K and ROSENKRANZ, B},
  issn         = {0009-9236},
  journal      = {CLINICAL PHARMACOLOGY \& THERAPEUTICS},
  language     = {eng},
  number       = {1},
  pages        = {24--30},
  title        = {SINGLE-DOSE PHARMACOKINETICS OF CEFPIROME IN PATIENTS WITH RENAL IMPAIRMENT.},
  volume       = {52},
  year         = {1992},
}